|
Schwartz GG, Eads D, Rao A, Cramer SD, Willingham MC, Chen TC, Jamieson DP, Wang L, Burnstein KL, Holick MF, Koumenis C. Pancreatic cancer cells express 25-Hydroxyvitamin D-1-α-Hydroxylase and their proliferation is inhibited by the prohormone 25-Hydroxyvitamin D3
Carcinogenesis
Young MV, Schwartz GG, Wang L, Jamieson DP, Whitlatch LW, Flanagan JN, Lokeshwar BL, Holick MF, Chen TC. The prostate 25-Hydroxyvitamin D-1-α-Hydroxylase is not influenced by parathyroid hormone and calcium: Implications for prostate cancer chemoprevention by vitamin D
Carcinogenesis
Molnar I, Kute T, Willingham MC, Powell BL, Dodge WH, Schwartz GG. 19-nor-1-α,25-dihydroxyvitamin D2 (paricalcitol): Effects on clonal proliferation, differentiation and apoptosis in human leukemic cell lines
Journal of Cancer Research and Clinical Oncology
Chen TC, Holick MF, Lokeshwar BL, Burnstein KL, Schwartz GG. Evaluation of vitamin D analogs as therapeutic agents for prostate cancer
Recent Results in Cancer Research
Dunlap N, Schwartz GG, Eads D, Cramer SD, Sherk AB, John V, Koumenis C. 1-α,25(OH)2D (calcitriol) and its analogue, 19-nor-1-α-25(OH)2D2, potentiate the effects of ionising radiation on prostate cancer cells
British Journal of Cancer
Schwartz GG. Hypothesis: Does ochratoxin A cause testicular cancer
Cancer Causes and Control
Perez-Stable CM, Schwartz GG, Farinas A, Finegold M, Binderup L, Howard GA, Roos BA. The Gγ/T-15 transgenic mouse model of androgen-independent prostate cancer: Target cells of carcinogenesis and the effect of the vitamin D analogue, EB 1089
Cancer Epidemiology, Biomarkers and Prevention
Whitlatch LW, Young MV, Schwartz GG, Flanagan JN, Burnstein KL, Lokeshwar BL, Rich ES, Holick MF, Chen TC. 25-Hydroxyvitamin D-1-α-hydroxylase activity is diminished in human prostate cancer cells and is enhanced by gene transfer
Journal of Steroid Biochemistry & Molecular Biology
Dr. Schwartz, Gary
Dirección profesional:
Comprehensive Cancer Center of Wake Forest University Medical Center Boulevard. Winston-Salem, NC 27157
|
